Ariel Hurley Blueprint Medicines Corp (BPMC) insider trading activity

BPMC Quotes by TradingView

Ariel Hurley is Principal Accounting Officer of Blueprint Medicines Corp. Currently has a direct ownership of 0 shares of BPMC, which is worth approximately $0. The most recent transaction as insider was on Mar 01, 2023, when has been sold 5,425 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Ariel Hurley Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 01 2023
BUY
Grant, award, or other acquisition
-
5,425 Added 26.17%
15,301 Common Stock
Mar 10 2022
SELL
Open market or private sale
$133,674 $57.15 p/Share
2,339 Reduced 19.57%
9,616 Common Stock
Mar 07 2022
SELL
Open market or private sale
$14,385 $56.19 p/Share
256 Reduced 2.1%
11,955 Common Stock
Mar 03 2022
SELL
Open market or private sale
$45,865 $60.27 p/Share
761 Reduced 5.87%
12,211 Common Stock
Mar 01 2022
BUY
Grant, award, or other acquisition
-
2,875 Added 18.14%
12,972 Common Stock
Nov 16 2021
SELL
Open market or private sale
$222,846 $114.28 p/Share
1,950 Reduced 16.19%
10,097 Common Stock
Nov 16 2021
BUY
Exercise of conversion of derivative security
$16,692 $8.56 p/Share
1,950 Added 13.93%
12,047 Common Stock
Sep 23 2021
SELL
Open market or private sale
$66,000 $110.0 p/Share
600 Reduced 5.61%
10,097 Common Stock
Sep 23 2021
BUY
Exercise of conversion of derivative security
$9,006 $15.01 p/Share
600 Added 5.31%
10,697 Common Stock
Sep 13 2021
SELL
Open market or private sale
$60,000 $100.0 p/Share
600 Reduced 5.61%
10,097 Common Stock
Sep 13 2021
BUY
Exercise of conversion of derivative security
$9,006 $15.01 p/Share
600 Added 5.31%
10,697 Common Stock
Aug 17 2021
SELL
Open market or private sale
$124,106 $91.93 p/Share
1,350 Reduced 11.79%
10,097 Common Stock
Aug 17 2021
BUY
Exercise of conversion of derivative security
$7,209 $5.34 p/Share
1,350 Added 10.55%
11,447 Common Stock
Jun 01 2021
SELL
Open market or private sale
$21,726 $91.67 p/Share
237 Reduced 2.29%
10,097 Common Stock
May 17 2021
SELL
Open market or private sale
$290,225 $95.0 p/Share
3,055 Reduced 23.23%
10,097 Common Stock
May 17 2021
BUY
Exercise of conversion of derivative security
$7,209 $5.34 p/Share
1,350 Added 9.31%
13,152 Common Stock
Mar 04 2021
SELL
Open market or private sale
$75,347 $87.92 p/Share
857 Reduced 6.77%
11,799 Common Stock
Mar 03 2021
SELL
Open market or private sale
$50,702 $98.45 p/Share
515 Reduced 3.91%
12,656 Common Stock
Mar 01 2021
SELL
Open market or private sale
$169,167 $99.51 p/Share
1,700 Reduced 11.43%
13,171 Common Stock
Mar 01 2021
BUY
Exercise of conversion of derivative security
$9,078 $5.34 p/Share
1,700 Added 10.26%
14,871 Common Stock
Mar 01 2021
BUY
Grant, award, or other acquisition
-
3,187 Added 19.48%
13,171 Common Stock
Dec 01 2020
SELL
Open market or private sale
$113,703 $109.54 p/Share
1,038 Reduced 9.42%
9,984 Common Stock
Dec 01 2020
BUY
Exercise of conversion of derivative security
$7,920 $8.8 p/Share
900 Added 7.64%
10,884 Common Stock
Nov 16 2020
SELL
Open market or private sale
$171,564 $100.92 p/Share
1,700 Reduced 14.55%
9,984 Common Stock
Nov 16 2020
BUY
Exercise of conversion of derivative security
$9,078 $5.34 p/Share
1,700 Added 12.7%
11,684 Common Stock
AH

Ariel Hurley

Principal Accounting Officer
Cambridge, MA

Track Institutional and Insider Activities on BPMC

Follow Blueprint Medicines Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BPMC shares.

Notify only if

Insider Trading

Get notified when an Blueprint Medicines Corp insider buys or sells BPMC shares.

Notify only if

News

Receive news related to Blueprint Medicines Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BPMC